Janux Therapeutics, Inc.
Janux Therapeutics, Inc. (JANX) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
janx · stock forecast · 15 analysts (3M) · FMP · updated Jun 8, 2026
Analyst Rating & Consensus
Based on 15 Wall Street analysts in the past 3 months
Buy
15 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$36.00
Consensus
$23.40
+73.2% upside
Low
$14.00
Median: $22 · Last Close: $13.51
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$23.40
73.2% upside
High Target
$36
166.5%
Low Target
$14
3.6%
Current Price
$13.51
as of today
Based on analyst price targets, the JANX stock price prediction for the next 12 months ranges from $14 to $36. The consensus JANX price forecast of $23.40 implies 73.2% upside from the current price of $13.51.
Short-Term Price Prediction
Algorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $13.15 | ↓ 2.69% |
1-day model range: $13.1–$13.2. Peak: $13.2 (-2.69%).
Long-Term Stock Price Prediction
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · JANX · Jun 8, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-08 | Guggenheim | Maintains | Buy→Buy |
| 2026-05-08 | Piper Sandler | Maintains | Overweight→Overweight |
| 2026-05-08 | Wedbush | Maintains | Outperform→Outperform |
| 2026-04-28 | Jones Trading | Maintains | Buy→Buy |
| 2026-04-20 | Barclays | Downgrade ↓ | Overweight→Underweight |
| 2026-04-15 | UBS | Downgrade ↓ | Buy→Neutral |
| 2026-02-27 | Guggenheim | Maintains | Buy→Buy |
| 2026-02-27 | Cantor Fitzgerald | Maintains | Overweight→Overweight |
| 2026-01-20 | Clear Street | Downgrade ↓ | Buy→Hold |
| 2026-01-16 | Piper Sandler | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Janux Therapeutics, Inc. (JANX) stock. Of the recent 52 rating actions, 0 were upgrades and 3 were downgrades. 15 analysts currently cover JANX.
Analyst Recommendation Trends
JANX analyst recommendation trends show increasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 3 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$29M
↑ 57.3% YoY
Revenue Next Year
$7M
↓ 76.3% YoY
EPS This Year
$-1.77
EPS Next Year
$-2.74
↑ 54.8% YoY
EPS ForecastReported vs Estimated
Analysts forecast JANX EPS of $-1.77 for the current fiscal year, based on estimates from 12 analysts. The JANX revenue forecast is $29M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The JANX stock forecast is supported by two independent data sources: analyst consensus ratings from 15 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus JANX price target is $23.40 (+73.2% upside), with an analyst consensus of Buy.
The JANX short-term stock prediction for tomorrow is $13.15 (-2.69%).
Janux Therapeutics, Inc. trades on NASDAQ under the ticker JANX. The JANX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 73% of covering analysts.
Frequently asked questions
JANX forecast · 8 questionsAccording to 15 Wall Street analysts, the average 12-month JANX price target is $23.40, with a high forecast of $36.00 and a low of $14.00. The median price target is shown in the chart above when available. This implies +73.2% potential upside from the current price of $13.51.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.